KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the ...

Systems announced a collaboration with a global pharmaceutical manufacturer on a Phase III clinical trial for an expanded ...

Systems (NASDAQ: KRMD), a medical technology firm with a market capitalization of $194 million, announced a partnership with a global pharmaceutical manufacturer to conduct a Phase III clinical trial.

Analysts have recently evaluated KORU Medical Systems and provided 12-month price targets. The average target is $4.7, ...

The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us. Below, we take a look at KORU Medical Systems Inc. (KRMD), a company that currently holds a Momentum ...

Airbnb, Inc. today announced that the company's fourth quarter and full year 2024 financial results will be released after market close on Thursday, February 13, 2025. The company's shareholder letter ...

Craig-Hallum raised the firm’s price target on Koru Medical (KRMD) to $6 from $5 and keeps a Buy rating on the shares. Koru Medical’s Q4 ...

Throughout the last three months, 5 analysts have evaluated KORU Medical Systems (NASDAQ:KRMD), offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view ...

Azenta, Inc. today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics and a recognized leader in the biotechnology and pharmaceutical industries, has been elected to its Board ...

Analysts at B. Riley boosted their FY2024 EPS estimates for shares of KORU Medical Systems in a research report issued on Tuesday, January 14th. B. Riley analyst K. Bauser now forecasts that the ...

Systems Inc. (NASDAQ:KRMD) to $6.00, up from the previous target of $5.00, while maintaining a Buy rating on the stock.